DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

173 hedge funds and large institutions have $1.4B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

15% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 66

69% less call options, than puts

Call options by funds: $1.51M | Put options by funds: $4.79M

Holders
173
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.51M
Puts
$4.79M
Net Calls
Net Calls Change

Top Buyers

1 +$52.1M
2 +$24.5M
3 +$19.5M
4
CCM
CAAS Capital Management
New York
+$10.8M
5
Goldman Sachs
Goldman Sachs
New York
+$8.31M

Top Sellers

1 -$22M
2 -$12.7M
3 -$10.2M
4
BM
Bridger Management
New York
-$9.05M
5
State Street
State Street
Massachusetts
-$7.03M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.44M
77
$1.38M
78
$1.34M
79
$1.31M
80
$1.28M
81
$1.24M
82
$1.21M
83
$1.2M
84
$1.2M
85
$1.15M
86
$1.09M
87
$1.07M
88
$1.05M
89
$1.04M
90
$930K
91
$909K
92
$881K
93
$880K
94
$839K
95
$836K
96
$815K
97
$801K
98
$720K
99
$708K
100
$705K